CTOs on the Move

Adelphi Technology Inc

www.adelphitech.com

 
Adelphi Technology Inc is a Redwood City, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $250-500 Million

Executives

Name Title Contact Details

Similar Companies

Central Blood Bank

Central Blood Bank is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HealthFair

HealthFair is a Winter Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Carr Devt Svcs Unvrsty

Carr Devt Svcs Unvrsty is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Biofire Diagnostics

With more than 25 years of molecular experience, BioFire Diagnostics, LLC sets the standard for molecular diagnostics through its pioneering advances in syndromic infectious disease testing. As BioMérieux`s Global Center of Excellence for Molecular Diagnostics, no other company has FDA-cleared and CE-IVD marked assays for more pathogens. BioFire Diagnostics has produced the easiest, fastest, and most comprehensive multiplex PCR testing available: the BioFire® FilmArray® System.

Gritstone Oncology

Gritstone Oncology is a privately-held company headquartered in the San Francisco Bay Area with key functions located in Cambridge, Massachusetts and Pleasanton, California. We launched in October 2015, and since inception, have successfully raised two large, private financing rounds. We currently employ more than 60 professionals. We have brought together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to tackle fundamental challenges at the intersection of cancer genomics and immunotherapy. With our unique approach to immuno-oncology, we are developing next-generation personalized immunotherapies to fight cancer in patients with the most difficult-to-treat tumors. We plan to combine these personalized neoantigen-targeted therapies with current immune checkpoint modulatory approaches to improve response rates and survival in patients with solid tumors.